FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2898839007> ?p ?o ?g. }

• W2898839007 endingPage "115" @default.
• W2898839007 startingPage "101" @default.
• W2898839007 abstract "Immunotherapy is a combination of therapeutic strategies that make use of a patient’s immune system to confront tumors. Over the past few years, immunotherapy has evolved as a crucial therapeutic program to manage some types of cancer. Our immune system is a collection of cells and tissues which perform the specialized function of defending our body against foreign pathogens. Although our immune system is designed to combat foreign agents that pose a threat, it often fails to detect and eradicate tumor cells because tumor cells have evolved complex genetic adaptive mechanisms that help them evade the immune surveillance program. In order to overcome this obstacle and in order to improve tumor cell detection and eradication by the immune system, researchers have developed a novel therapeutic treatment strategy called chimeric antigen receptor T cell therapy (CAR-T cell therapy). T cells are immune cells that play a key role in shielding our body against foreign pathogens by mounting a potent immune response that ultimately eradicates abnormal cells. In brief, CAR-T cell therapy involves the isolation of T cells from patient blood, genetically altering the T cells to express receptors on their surface that specifically can bind to antigens present on the tumor cell, proliferating them in the laboratory to make millions of cells and finally, injecting back into the patient. T cells genetically manipulated in this manner harbor the capacity of multiplying inside the patient’s body and can also eradicate tumor cells that express surface antigens specifically recognized by the engineered receptor. It took researchers all around the globe several years of research to have CAR-T cell therapy approved in August 2017 for the treatment of children with acute lymphoblastic leukemia (ALL). So far, CAR-T cell therapy has shown extremely promising results in patient populations, especially for patients who have developed chemo-resistance. The scope of this chapter is to provide a broad and general idea about all the different aspects of CAR-T cell therapy that are essential for the application of this therapeutic strategy to combat cancer. Some of these key features include selection of a specific tumor antigen to target, developing a strong co-stimulatory signaling strategy to elicit a potent immune response, enhancing the migratory properties of CAR-T cells so that they can localize to tumor sites, and finally, engineering T cells in a manner so that they can effectively proliferate and eliminate tumor cells. In conclusion, CAR-T cells hold tremendous potential for the treatment of cancer and have shown promising results in clinical trials." @default.
• W2898839007 created "2018-11-09" @default.
• W2898839007 creator A5023600505 @default.
• W2898839007 creator A5074718111 @default.
• W2898839007 date "2018-11-04" @default.
• W2898839007 modified "2023-09-26" @default.
• W2898839007 title "CAR-T Cell Immune Therapy: Engineering T Cells to Treat Cancer" @default.
• W2898839007 cites W1541573460 @default.
• W2898839007 cites W1595135214 @default.
• W2898839007 cites W1623064933 @default.
• W2898839007 cites W1624657716 @default.
• W2898839007 cites W1652473508 @default.
• W2898839007 cites W1943676235 @default.
• W2898839007 cites W1966542058 @default.
• W2898839007 cites W1983056774 @default.
• W2898839007 cites W1984287161 @default.
• W2898839007 cites W1984550821 @default.
• W2898839007 cites W1987504267 @default.
• W2898839007 cites W1988450289 @default.
• W2898839007 cites W1999843922 @default.
• W2898839007 cites W2001327683 @default.
• W2898839007 cites W2001692330 @default.
• W2898839007 cites W2003494920 @default.
• W2898839007 cites W2004347994 @default.
• W2898839007 cites W2004630197 @default.
• W2898839007 cites W2009709218 @default.
• W2898839007 cites W2010607826 @default.
• W2898839007 cites W2012694659 @default.
• W2898839007 cites W2013464021 @default.
• W2898839007 cites W2014154395 @default.
• W2898839007 cites W2015776124 @default.
• W2898839007 cites W2016867672 @default.
• W2898839007 cites W2017874886 @default.
• W2898839007 cites W2019850188 @default.
• W2898839007 cites W2020099065 @default.
• W2898839007 cites W2020312840 @default.
• W2898839007 cites W2024997807 @default.
• W2898839007 cites W2025441867 @default.
• W2898839007 cites W2028460943 @default.
• W2898839007 cites W2032803186 @default.
• W2898839007 cites W2036442735 @default.
• W2898839007 cites W2037593657 @default.
• W2898839007 cites W2039721940 @default.
• W2898839007 cites W2040468807 @default.
• W2898839007 cites W2040572245 @default.
• W2898839007 cites W2042582068 @default.
• W2898839007 cites W2047192675 @default.
• W2898839007 cites W2047420649 @default.
• W2898839007 cites W2051549641 @default.
• W2898839007 cites W2056662191 @default.
• W2898839007 cites W2057389857 @default.
• W2898839007 cites W2061225353 @default.
• W2898839007 cites W2064510700 @default.
• W2898839007 cites W2068890283 @default.
• W2898839007 cites W2076668490 @default.
• W2898839007 cites W2076823120 @default.
• W2898839007 cites W2076991609 @default.
• W2898839007 cites W2082708772 @default.
• W2898839007 cites W2083262808 @default.
• W2898839007 cites W2087055812 @default.
• W2898839007 cites W2092475062 @default.
• W2898839007 cites W2093334570 @default.
• W2898839007 cites W2094945699 @default.
• W2898839007 cites W2098686083 @default.
• W2898839007 cites W2099694564 @default.
• W2898839007 cites W2100412095 @default.
• W2898839007 cites W2101687598 @default.
• W2898839007 cites W2105400883 @default.
• W2898839007 cites W2107806760 @default.
• W2898839007 cites W2110500254 @default.
• W2898839007 cites W2113802879 @default.
• W2898839007 cites W2116314778 @default.
• W2898839007 cites W2125203692 @default.
• W2898839007 cites W2134013248 @default.
• W2898839007 cites W2136100686 @default.
• W2898839007 cites W2136371915 @default.
• W2898839007 cites W2139994202 @default.
• W2898839007 cites W2140066663 @default.
• W2898839007 cites W2141262236 @default.
• W2898839007 cites W2143626441 @default.
• W2898839007 cites W2152943305 @default.
• W2898839007 cites W2155250860 @default.
• W2898839007 cites W2156106286 @default.
• W2898839007 cites W2156871337 @default.
• W2898839007 cites W2161958391 @default.
• W2898839007 cites W2165580475 @default.
• W2898839007 cites W2167550136 @default.
• W2898839007 cites W2176267409 @default.
• W2898839007 cites W2313910578 @default.
• W2898839007 cites W2317553789 @default.
• W2898839007 doi "https://doi.org/10.1007/978-3-319-92399-4_7" @default.
• W2898839007 hasPublicationYear "2018" @default.
• W2898839007 type Work @default.
• W2898839007 sameAs 2898839007 @default.
• W2898839007 citedByCount "0" @default.
• W2898839007 crossrefType "book-chapter" @default.
• W2898839007 hasAuthorship W2898839007A5023600505 @default.
• W2898839007 hasAuthorship W2898839007A5074718111 @default.

• next